Bioptik Technology Asset Resilience Ratio

Latest as of December 2025: 3.12%

Bioptik Technology asset resilience ratio. Bioptik Technology (4161) has an Asset Resilience Ratio of 3.12% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Bioptik Technology defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

NT$49.08 Million

≈ $1.55 Million USD Cash + Short-term Investments

Total Assets

NT$1.57 Billion

≈ $49.52 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Bioptik Technology (2017–2025)

Asset resilience ratio of Bioptik Technology from 2017 to 2025. This chart shows how Bioptik Technology's Asset Resilience Ratio has changed over time. Read Bioptik Technology (4161) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Bioptik Technology's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Bioptik Technology (4161) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$49.08 Million	3.12%
Total Liquid Assets	NT$49.08 Million	3.12%

Asset Resilience Insights

Limited Liquidity: Bioptik Technology maintains only 3.12% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Bioptik Technology Industry Peers by Asset Resilience Ratio

Compare Bioptik Technology's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
BMC Medical Co. Ltd. A SHE:301367	Medical Devices	44.96%
Emvision Medical Devices Ltd AU:EMV	Medical Devices	0.06%
Hironic Co. Ltd KQ:149980	Medical Devices	17.42%
DRGEM Corporation KQ:263690	Medical Devices	2.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Adherium Ltd AU:ADR	Medical Devices	15.45%

Bioptik Technology Asset Resilience Ratio by Year (2017–2025)

Bioptik Technology asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Bioptik Technology.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	3.12%	NT$49.08 Million ≈ $1.55 Million	NT$1.57 Billion ≈ $49.52 Million	+0.32pp
2024-12-31	2.80%	NT$41.63 Million ≈ $1.31 Million	NT$1.49 Billion ≈ $46.87 Million	+1.09pp
2023-12-31	1.70%	NT$25.51 Million ≈ $803.83K	NT$1.50 Billion ≈ $47.19 Million	+0.25pp
2022-12-31	1.46%	NT$22.08 Million ≈ $695.58K	NT$1.52 Billion ≈ $47.74 Million	-14.36pp
2021-12-31	15.81%	NT$240.97 Million ≈ $7.59 Million	NT$1.52 Billion ≈ $48.01 Million	+5.52pp
2020-12-31	10.29%	NT$151.71 Million ≈ $4.78 Million	NT$1.47 Billion ≈ $46.43 Million	+7.17pp
2019-12-31	3.12%	NT$48.51 Million ≈ $1.53 Million	NT$1.55 Billion ≈ $48.97 Million	-16.95pp
2018-12-31	20.07%	NT$321.95 Million ≈ $10.14 Million	NT$1.60 Billion ≈ $50.53 Million	+4.55pp
2017-12-31	15.52%	NT$242.96 Million ≈ $7.65 Million	NT$1.57 Billion ≈ $49.32 Million	--

pp = percentage points

About Bioptik Technology

TWO:4161 Taiwan Medical Devices

Market Cap

$39.48 Million

NT$1.25 Billion TWD

Market Cap Rank

#22567 Global

#1410 in Taiwan

Share Price

NT$20.95

Change (1 day)

-0.71%

52-Week Range

NT$20.95 - NT$27.00

All Time High

NT$69.78